Aprotinin

Раствор By prescription

Proteolysis inhibitor (solution)

Aprotinin

Indications

Pancreatitis (acute, exacerbation of chronic), pancreonecrosis. Performing diagnostic studies and operations on the pancreas (prevention of enzymatic autolysis of the pancreas during operations on it and nearby abdominal organs).

Prevention of acute non-specific postoperative parotitis.

Bleeding on the background of hyperfibrinolysis: posttraumatic, postoperative (especially in operations on the prostate gland, lungs), before, after and during childbirth (including embolism with amniotic fluid); polymenorrhoea.

Angioneurotic oedema.

Shock (toxic, traumatic, burn, haemorrhagic).

Extensive and deep traumatic tissue injuries.

As adjuvant therapy - coagulopathies characterised by secondary hyperfibrinolysis (in the initial phase, before the onset of the effect after the use of heparin and replacement of clotting factors); massive bleeding (during thrombolytic therapy), during extracorporeal circulation.

Prevention of postoperative pulmonary embolism and bleeding; fat embolism in polytrauma, especially in fractures of the lower limbs and skull bones.

Contraindications

DIC (except for the phase of coagulopathy), I and III trimesters of pregnancy, lactation, hypersensitivity to aprotinin, hypersensitivity to bovine protein.

Usage

Индивидуальный, в зависимости от показаний и клинической ситуации. Вводят в/в в виде кратковременной или длительной инфузии.

В среднем начальная доза составляет 500 000 КИЕ, поддерживающая - 50 000 КИЕ/ч.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.